help button home button The Oncologist
HOME HELP CONTACT US SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Abstract
Right arrow Full Text
Right arrow eLetters: Submit a response to this article
Services
Right arrow E-mail this article link to a friend
Right arrow Alert me to new issues of the journal
Right arrow Reprints/Permissions
Osteopontin Combined with CD44, a Novel Prognostic Biomarker for Patients with Hepatocellular Carcinoma Undergoing Curative Resection
Oncologist Yang et al. 13: 1155

Supplemental Data

Files in this Data Supplement:



This Article
Right arrow Abstract
Right arrow Full Text
Right arrow eLetters: Submit a response to this article
Services
Right arrow E-mail this article link to a friend
Right arrow Alert me to new issues of the journal
Right arrow Reprints/Permissions

HOME HELP CONTACT US SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
THE ONCOLOGIST STEM CELLS CME ALPHAMED PRESS JOURNALS